According to the report, the global rapid medical diagnostic kits market is likely to grow from USD 19.6 Billion in 2025 to USD 42.1 Billion in 2035 at a highest CAGR of 7.2% during the time period. The rapid medical diagnostic kits market has been increasing globally through a combination of increasing infectious disease burden, technological innovation and evolving healthcare delivery models. Malaria, dengue, HIV/AIDS and repeated epidemics of COVID-19 have increased the strain on the rapid, reliable diagnostics, especially in those areas where the laboratory infrastructure is weak.
Improved speed, accuracy, and ease of use technological innovation (particularly in biosensors, microfluidics, lateral flow assays and AI-based diagnostics) has seen manufacturers such as Abbott, Roche and Danaher introduce multiplex and point-of-care test kits, with minimal training and providing rapid results. Regulatory push (global organizations, as well as local agencies, are also offering funding) is being given by the aid of public health agencies to the manufacturing of rapid tests with local manufacturers-WHO support of national manufacturers (such as the production of rapid test kits of HIV and malaria) in Nigeria with the help of SD Biosensor shows the expansion of the local capacity in response to funding cuts. Increasing the focus on home-based testing, chronic disease monitoring (e.g. diabetes and cardiovascular disease), and preventive health programs also create demand.
The rapid move towards decelerated healthcare is a powerful force contributing to the global rapid medical diagnostic kits market, as patients are beginning to seek care in pharmacies, retail clinics, and home-based environments much more than they used to depend only on hospitals. This change is increasing the need to use portable and quick-result kits that will enable point-of-care decision-making. An example is CVS Health in the U.S. that in 2024 increased its services of at-home rapid COVID-19 and flu testing to reduce hospital workload and help in the delivery of care in the community.
The biggest limitation is that the issue of false positives and false negatives in test results remains constant and affects the clinical reliability and confidence of the user. Non-accuracy may lead to medical error, late treatment or unwanted treatment, particularly in an emergency. As an illustration, in 2023 the FDA of the United States provided warnings about some antigen COVID-19 rapid tests produced by Ellume because of the excessively elevated level of false positive results, which emphasizes the dangers of poor quality control.
The prospective opportunity is in the combination of rapid diagnostic kit and digital platforms to manage health conveniently. Coupled with smartphones or cloud systems, such kits do not only deliver results, but also supply real-time data to healthcare providers and public health agencies. In 2024, Abbott collaborated with digital health to integrate its BinaxNOW COVID-19 on-the-fly test findings to telemedicine services, which shows how diagnostic equipment is changing to linked solutions to boost disease monitoring and individualized treatment.
Prominent players operating in the global rapid medical diagnostic kits market are Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., Becton, Dickinson and Company (BD), bioMérieux SA, Bionime Corporation, Bio-Rad Laboratories, Inc., Cardinal Health Inc., Chembio Diagnostic Systems, Inc., Danaher Corporation (Cepheid), Everlywell, Inc., F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., Nova Biomedical, OraSure Technologies, Inc., QuidelOrtho Corporation, Sekisui Diagnostics, LLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech plc, and Other Key Players.
MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.
800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.
+1(302)303-2617
info@marketgenics.co
3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.
sales@marketgenics.co
Table of Contents
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
We will customise the research for you, in case the report listed above does not meet your requirements.
Get 10% Free Customisation